Future Therapies and Clinical Trials

  • Colin G. Miller


The diagnosis and treatment of osteoporosis is still a relatively young science. Although Albright first described osteoporosis in 19471 it is only since the late 1980s and early 1990s that we have had the instruments available to us for the diagnosis and then treatment of this disease. Like any medical area in its infancy, we can therefore expect a significant number of changes in the coming years, as the understanding of bone physiology becomes more comprehensive and the genetic factors leading to increased risk factors become known.


Anorexia Nervosa Osteogenesis Imperfecta Future Therapy Bone Physiology Male Osteoporosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Albright F. Annals of Internal Medicine Volume 27, 1947: Osteoporosis. Nutr Rev 1989; 47: 85–6.Google Scholar
  2. 2.
    Hollingworth W, Todd CJ, Parker MJ. The cost of treating hip fractures in the twenty-first century: short report. Osteoporos Int 1996; 6 (Suppl 2): 13–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Lindsay R, Cosman F, Lobo RA, Walsh BW, Harris ST, Reagan JE, Liss CL, Melton ME, Byrnes CA. Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial. J Clin Endocrinol Metab 1999; 84 (9): 3076–81.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2002

Authors and Affiliations

  • Colin G. Miller

There are no affiliations available

Personalised recommendations